News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News Hospitals should be fined for failing to innovate - report Government must get tough to encourage innovation, say peers.
Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
News NHS proposes crackdown on erectile dysfunction drugs and sun... Eli Lilly's Cialis named on list of drugs no longer consider cost-effective.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
Gilead Wales experts back HIV prophlyaxis, ahead of key meetings Cost-effectiveness bodies in Wales and Scotland to decide on Truvada in April.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.